Sinusave

Sinusave

Early Stage

The Drug Free Nasal Congestion Solution

The Drug Free Nasal Congestion Solution

Overview

Raised to Date: Raised: $0

Total Commitments ($USD)

Platform

Razitall

Start Date

01/22/2020

Close Date

06/08/2020

Min. Goal
$537,000
Max. Goal
$600,000
Min. Investment

$269

Security Type

CAFES

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$3,977,777

Discount

0%

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

06/09/2020

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$0

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

Non-Tech

Distribution Model

B2B/B2C

Margin

High

Capital Intensity

Low

Location

Ashton, Maryland

Business Type

Life Style

SinuSave, a drug-free nasal congestion solution, is raising funds on Razitall. It is the only patented all-natural solution for a daily nasal wash to keep the sinuses clean. Sinusave is safe for all age groups above three and is saline-free. It can be marketed over-the-counter in pharmacies, health stores, supermarket pharmacies, wellness product catalogs, and online. Sinusave was founded by Paul A. Lobel, with decades of experience in sales and marketing and research & development. The current crowdfunding round has a target raise of $537,000, and the proceeds will be used for advertising, payment of salaries, expansion of product catalog, and beefing up of point of sales assets at independent health stores. Sinusave formulations have been in production since March 2018, and they are manufactured in an FDA-certified facility.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$19,793

$0

COGS

$19,661

$0

Tax

$0

$0

 

 

Net Income

$-230,400

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$7,100

$0

Accounts Receivable

$429

$0

Total Assets

$58,398

$0

Short-Term Debt

$73,230

$0

Long-Term Debt

$150,818

$0

Total Liabilities

$224,048

$0

Financials as of: 01/22/2020
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Sinusave on Razitall
Platform: Razitall
Security Type: CAFES
Valuation: $3,977,777

Follow company

Follow Sinusave on Razitall

Buy Sinusave's Deal Report

Warning: according to the close date for this deal, Sinusave may no longer be accepting investments.

Sinusave Deal Report

Get KingsCrowd’s comprehensive report on Sinusave including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Sinusave is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Sinusave deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge